$LCTX
Lineage Cell Therapeutics, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024127077 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $3.779M $1.200M
YoY Change 214.92% -60.0%
Cost Of Revenue $38.00K $169.0K
YoY Change -77.51% -28.09%
Gross Profit $3.741M $1.077M
YoY Change 247.35% -61.02%
Gross Profit Margin 98.99% 89.75%
Selling, General & Admin $4.410M $4.040M
YoY Change 9.16% -8.64%
% of Gross Profit 117.88% 375.12%
Research & Development $3.171M $3.741M
YoY Change -15.24% 4.15%
% of Gross Profit 84.76% 347.35%
Depreciation & Amortization $141.0K $170.0K
YoY Change -17.06% -11.92%
% of Gross Profit 3.77% 15.78%
Operating Expenses $3.171M $7.782M
YoY Change -59.25% -2.89%
Operating Profit -$3.840M -$6.705M
YoY Change -42.73% 27.69%
Interest Expense $397.0K $370.0K
YoY Change 7.3% 145.03%
% of Operating Profit
Other Income/Expense, Net $839.0K -$453.0K
YoY Change -285.21% 39.81%
Pretax Income -$3.001M -$7.158M
YoY Change -58.07% 28.39%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.034M -$7.110M
YoY Change -57.33% 17.15%
Net Earnings / Revenue -80.29% -592.5%
Basic Earnings Per Share -$0.02 -$0.04
Diluted Earnings Per Share -$0.02 -$0.04
COMMON SHARES
Basic Shares Outstanding 188.8M 188.8M 175.0M shares
Diluted Shares Outstanding 188.8M 174.9M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.71M $41.30M
YoY Change -20.8% -37.76%
Cash & Equivalents $27.75M $31.47M
Short-Term Investments $4.961M $9.900M
Other Short-Term Assets $1.285M $1.700M
YoY Change -24.41% -1.16%
Inventory
Prepaid Expenses
Receivables $405.0K $432.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $34.40M $43.48M
YoY Change -20.88% -36.53%
LONG-TERM ASSETS
Property, Plant & Equipment $2.013M $4.854M
YoY Change -58.53% 4.34%
Goodwill $10.67M $10.67M
YoY Change 0.0% 0.0%
Intangibles $46.54M $46.59M
YoY Change -0.12% -0.28%
Long-Term Investments
YoY Change
Other Assets $606.0K $600.0K
YoY Change 1.0% 1.52%
Total Long-Term Assets $62.19M $62.67M
YoY Change -0.76% 0.05%
TOTAL ASSETS
Total Short-Term Assets $34.40M $43.48M
Total Long-Term Assets $62.19M $62.67M
Total Assets $96.59M $106.2M
YoY Change -9.0% -19.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.599M $2.430M
YoY Change -34.2% -15.18%
Accrued Expenses $384.0K $349.0K
YoY Change 10.03% -93.02%
Deferred Revenue $9.900M
YoY Change -75.56%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $54.00K $100.0K
YoY Change -46.0% 300.0%
Total Short-Term Liabilities $13.86M $15.88M
YoY Change -12.7% -30.16%
LONG-TERM LIABILITIES
Long-Term Debt $80.00K $100.0K
YoY Change -20.0% 525.0%
Other Long-Term Liabilities $17.58M
YoY Change
Total Long-Term Liabilities $17.66M $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.86M $15.88M
Total Long-Term Liabilities $17.66M $0.00
Total Liabilities $31.80M $39.49M
YoY Change -19.48% -26.31%
SHAREHOLDERS EQUITY
Retained Earnings -$400.2M -$380.1M
YoY Change 5.29% 6.46%
Common Stock $469.3M $450.3M
YoY Change 4.22% 2.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.19M $68.12M
YoY Change
Total Liabilities & Shareholders Equity $96.59M $106.2M
YoY Change -9.0% -19.06%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$3.034M -$7.110M
YoY Change -57.33% 17.15%
Depreciation, Depletion And Amortization $141.0K $170.0K
YoY Change -17.06% -11.92%
Cash From Operating Activities -$5.787M -$5.040M
YoY Change 14.82% -8.03%
INVESTING ACTIVITIES
Capital Expenditures $112.0K $140.0K
YoY Change -20.0% -148.95%
Acquisitions
YoY Change
Other Investing Activities $4.000M $2.260M
YoY Change 76.99% -105.56%
Cash From Investing Activities $3.888M $2.120M
YoY Change 83.4% -105.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.000K 810.0K
YoY Change -100.37% -15.98%
NET CHANGE
Cash From Operating Activities -5.787M -5.040M
Cash From Investing Activities 3.888M 2.120M
Cash From Financing Activities -3.000K 810.0K
Net Change In Cash -1.902M -2.110M
YoY Change -9.86% -95.36%
FREE CASH FLOW
Cash From Operating Activities -$5.787M -$5.040M
Capital Expenditures $112.0K $140.0K
Free Cash Flow -$5.899M -$5.180M
YoY Change 13.88% -0.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000876343
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-12830
dei Entity Registrant Name
EntityRegistrantName
Lineage Cell Therapeutics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3127919
dei Entity Address Address Line1
EntityAddressAddressLine1
2173 Salk Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92008
dei City Area Code
CityAreaCode
442
dei Local Phone Number
LocalPhoneNumber
287-8990
dei Security12b Title
Security12bTitle
Common shares
dei Trading Symbol
TradingSymbol
LCTX
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
188837375
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27750000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35442000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4961000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
50000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
405000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
745000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1285000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2204000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
34401000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
38441000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2013000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2245000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2362000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2522000
CY2024Q3 lctx Deposits And Other Longterm Assets Non Current
DepositsAndOtherLongtermAssetsNonCurrent
606000
CY2023Q4 lctx Deposits And Other Longterm Assets Non Current
DepositsAndOtherLongtermAssetsNonCurrent
577000
CY2024Q3 us-gaap Goodwill
Goodwill
10672000
CY2023Q4 us-gaap Goodwill
Goodwill
10672000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46540000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46562000
CY2024Q3 us-gaap Assets
Assets
96594000
CY2023Q4 us-gaap Assets
Assets
101019000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4477000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6270000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1083000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
830000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
54000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
52000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8250000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10808000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13864000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17960000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
273000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
273000
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
16050000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
18693000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1533000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1979000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
80000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
91000
CY2024Q3 us-gaap Liabilities
Liabilities
31800000
CY2023Q4 us-gaap Liabilities
Liabilities
38996000
CY2024Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188837000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
188837000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
174987000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
174987000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
469268000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
451343000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2890000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3068000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-400192000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-384856000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
66186000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
63419000
CY2024Q3 us-gaap Minority Interest
MinorityInterest
-1392000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-1396000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
64794000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62023000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96594000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101019000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3779000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1246000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6631000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6857000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
38000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
169000
us-gaap Cost Of Revenue
CostOfRevenue
180000
us-gaap Cost Of Revenue
CostOfRevenue
415000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3171000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3741000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9049000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11799000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4410000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4041000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13770000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13014000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
7619000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
7951000
us-gaap Costs And Expenses
CostsAndExpenses
22999000
us-gaap Costs And Expenses
CostsAndExpenses
25228000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3840000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6705000
us-gaap Operating Income Loss
OperatingIncomeLoss
-16368000
us-gaap Operating Income Loss
OperatingIncomeLoss
-18371000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
397000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
433000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1322000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1225000
CY2024Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-6000
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-60000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-21000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-170000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
448000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-827000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-284000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1796000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
544000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
839000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-453000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1036000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-197000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3001000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7158000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15332000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18568000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1803000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-3001000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-7158000
us-gaap Profit Loss
ProfitLoss
-15332000
us-gaap Profit Loss
ProfitLoss
-16765000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
33000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-48000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-54000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3034000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7110000
us-gaap Net Income Loss
NetIncomeLoss
-15336000
us-gaap Net Income Loss
NetIncomeLoss
-16711000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
188835000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
188835000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174868000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174868000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
186860000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
186860000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
171880000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171880000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-3001000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-7158000
us-gaap Profit Loss
ProfitLoss
-15332000
us-gaap Profit Loss
ProfitLoss
-16765000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-432000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
518000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
173000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1337000
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
12000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
9000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
150000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3421000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6631000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-15154000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-15278000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
33000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-48000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
4000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-54000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3454000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6583000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15158000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15224000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
66875000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2024Q3 lctx Adjustments To Common Stock Share Based Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonStockShareBasedCompensationRequisiteServicePeriodRecognitionValue
1330000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-432000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-3001000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
64794000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
71258000
CY2023Q3 lctx Financing Related Fees
FinancingRelatedFees
-28000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000
CY2023Q3 lctx Adjustments To Common Stock Share Based Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonStockShareBasedCompensationRequisiteServicePeriodRecognitionValue
1269000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
518000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-7158000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
66660000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62023000
lctx Financing Related Fees
FinancingRelatedFees
-113000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
23000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
229000
lctx Adjustments To Common Stock Share Based Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonStockShareBasedCompensationRequisiteServicePeriodRecognitionValue
3762000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
173000
us-gaap Profit Loss
ProfitLoss
-15332000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
64794000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
71936000
lctx Financing Related Fees
FinancingRelatedFees
-221000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
37000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000
lctx Adjustments To Common Stock Share Based Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonStockShareBasedCompensationRequisiteServicePeriodRecognitionValue
3580000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
150000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1337000
us-gaap Profit Loss
ProfitLoss
-16765000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
66660000
us-gaap Net Income Loss
NetIncomeLoss
-15336000
us-gaap Net Income Loss
NetIncomeLoss
-16711000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-54000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-21000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-170000
lctx Accretion Of Income On Marketable Debt Securities
AccretionOfIncomeOnMarketableDebtSecurities
184000
lctx Accretion Of Income On Marketable Debt Securities
AccretionOfIncomeOnMarketableDebtSecurities
647000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
436000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
419000
lctx Change In Rightofuse Assets And Liabilities
ChangeInRightofuseAssetsAndLiabilities
-31000
lctx Change In Rightofuse Assets And Liabilities
ChangeInRightofuseAssetsAndLiabilities
86000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
98000
us-gaap Share Based Compensation
ShareBasedCompensation
3762000
us-gaap Share Based Compensation
ShareBasedCompensation
3580000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1803000
lctx Foreign Currency Remeasurement Gain Loss Before Tax And Other Loss
ForeignCurrencyRemeasurementGainLossBeforeTaxAndOtherLoss
-309000
lctx Foreign Currency Remeasurement Gain Loss Before Tax And Other Loss
ForeignCurrencyRemeasurementGainLossBeforeTaxAndOtherLoss
-1892000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-339000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
141000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-891000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-56000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1778000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3456000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-5201000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6036000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16746000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22547000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
18000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
196000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8761000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
16403000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4000000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
53497000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
200000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
583000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4943000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
36707000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
229000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
88000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
23000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
37000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14070000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6625000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
113000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
199000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
40000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
41000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14123000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6436000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-120000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-532000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7686000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20064000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35992000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11936000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28306000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32000000
us-gaap Interest Paid Net
InterestPaidNet
6000
us-gaap Interest Paid Net
InterestPaidNet
8000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27750000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31474000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
556000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
526000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28306000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32000000
us-gaap Proceeds From Collaborators
ProceedsFromCollaborators
14300000
CY2024Q3 lctx Cash And Cash Equivalents And Marketable Securities
CashAndCashEquivalentsAndMarketableSecurities
32700000
CY2024Q3 lctx Common Stock Capital Value Reserved For Future Issuance
CommonStockCapitalValueReservedForFutureIssuance
39970000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3386000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
957000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5671000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5949000
CY2024Q3 lctx Royalties License And Other Revenues
RoyaltiesLicenseAndOtherRevenues
393000
CY2023Q3 lctx Royalties License And Other Revenues
RoyaltiesLicenseAndOtherRevenues
289000
lctx Royalties License And Other Revenues
RoyaltiesLicenseAndOtherRevenues
960000
lctx Royalties License And Other Revenues
RoyaltiesLicenseAndOtherRevenues
908000
CY2024Q3 us-gaap Revenues
Revenues
3779000
CY2023Q3 us-gaap Revenues
Revenues
1246000
us-gaap Revenues
Revenues
6631000
us-gaap Revenues
Revenues
6857000
lctx Revenue Recognized From Deferred Revenue At Beginning Of Period
RevenueRecognizedFromDeferredRevenueAtBeginningOfPeriod
30000
lctx Revenue Recognized From Deferred Revenue At Beginning Of Period
RevenueRecognizedFromDeferredRevenueAtBeginningOfPeriod
87000
CY2023Q4 lctx Accounts Receivable Net Current Excludes Scope Of Asu201409
AccountsReceivableNetCurrentExcludesScopeOfAsu201409
676000
CY2022Q4 lctx Accounts Receivable Net Current Excludes Scope Of Asu201409
AccountsReceivableNetCurrentExcludesScopeOfAsu201409
297000
CY2024Q3 lctx Accounts Receivable Net Current Excludes Scope Of Asu201409
AccountsReceivableNetCurrentExcludesScopeOfAsu201409
392000
CY2023Q4 lctx Accounts Receivable Net Current Excludes Scope Of Asu201409
AccountsReceivableNetCurrentExcludesScopeOfAsu201409
676000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
29501000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
37146000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
24300000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
29501000
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12274000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
12281000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
8855000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8856000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
12274000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
12281000
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12274000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
12281000
CY2024Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-6000
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-60000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-21000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-170000
CY2024Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
CY2023Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-23000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-4000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-23000
CY2024Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-6000
CY2023Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-37000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-17000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-147000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4193000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3880000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2013000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2245000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
141000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
143000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
436000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
419000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
13000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
14000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
41000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
37000
CY2024Q3 us-gaap Goodwill
Goodwill
10672000
CY2023Q4 us-gaap Goodwill
Goodwill
10672000
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
66143000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
66143000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19603000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19581000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46540000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46562000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
98000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1599000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2050000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2494000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3123000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
384000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1097000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4477000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6270000
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
26759000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
29935000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2024Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188837375
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
188837375
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
174986671
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
174986671
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.50
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.24
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1330000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1269000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3762000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3580000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9500000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
us-gaap Effective Income Tax Rate Reconciliation Gilti Amount
EffectiveIncomeTaxRateReconciliationGiltiAmount
0
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation Gilti Amount
EffectiveIncomeTaxRateReconciliationGiltiAmount
0
CY2024Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1800000
us-gaap Operating Lease Payments
OperatingLeasePayments
913000
us-gaap Operating Lease Payments
OperatingLeasePayments
833000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
6000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
8000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
40000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
41000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
597000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
36000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
79000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1083000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
830000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1533000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1979000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2616000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2809000
CY2024Q3 lctx Finance Lease Liability Excluding Other Liabilities Current
FinanceLeaseLiabilityExcludingOtherLiabilitiesCurrent
54000
CY2023Q4 lctx Finance Lease Liability Excluding Other Liabilities Current
FinanceLeaseLiabilityExcludingOtherLiabilitiesCurrent
52000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
80000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
91000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
134000
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
143000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.063
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.07
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.069
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
us-gaap Operating Lease Expense
OperatingLeaseExpense
900000
us-gaap Operating Lease Expense
OperatingLeaseExpense
900000
CY2023Q1 lctx Insurance Deductable
InsuranceDeductable
25000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
lctx-20240930_htm.xml Edgar Link completed
0000950170-24-127077-index-headers.html Edgar Link pending
0000950170-24-127077-index.html Edgar Link pending
0000950170-24-127077.txt Edgar Link pending
0000950170-24-127077-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lctx-20240930.htm Edgar Link pending
lctx-20240930.xsd Edgar Link pending
lctx-ex31_1.htm Edgar Link pending
lctx-ex31_2.htm Edgar Link pending
lctx-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending